The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment

Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies

(2021) Lucila N Kerbauy et al.   CLINICAL CANCER RESEARCH

The core four - A panel of immunohistochemistry markers to diagnose and subtype testicular germ cell tumors

(2021) BVishal Rao et al.   Urology Annals

Breast implant–associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology

(2020) Louis‐André Julien et al.   CANCER CYTOPATHOLOGY

CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine‐needle aspiration cytology samples

(2019) Immacolata Cozzolino et al.   DIAGNOSTIC CYTOPATHOLOGY

Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30

(2018) Louise E. Hogan et al.   PLoS Pathogens

Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016

(2017) Akiko Miyagi Maeshima et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

IgG4-related Disease in Thymus. A Very Rare Case of Chronic Fibrosis Mimicking Sarcoidosis

(2017) Sara Simonetti et al.   TUMORI

Comparison of pediatric and adult lymphomas involving the mediastinum characterized by distinctive clinicopathological and radiological features

(2017) Lei Chen et al.   Scientific Reports

IgG4-related Disease in Thymus. A Very Rare Case of Chronic Fibrosis Mimicking Sarcoidosis

(2017) Sara Simonetti et al.   TUMORI JOURNAL

LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma

(2016) Dragan Jevremovic et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate types

(2015) Peter W. M. Johnson   HEMATOLOGICAL ONCOLOGY

Axillary Lymphadenopathy

(2015) Juan C. Tardío et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

(2015) Craig H Moskowitz et al.   LANCET

Brentuximab Vedotin in Transplant-Naive Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

(2015) P. L. Zinzani et al.   ONCOLOGIST

Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers

(2015) C. Carlo-Stella et al.   ONCOLOGIST

Diagnostic Utility of the Germinal Center–associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms

(2015) Thomas Menter et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma

(2014) Ariel Agur et al.   LEUKEMIA & LYMPHOMA

Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody–Drug Conjugates: Focus on Brentuximab Vedotin

(2013) Matthew Mei et al.   BIODRUGS

Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology

(2013) Ayoma D Attygalle et al.   HISTOPATHOLOGY

Malignant ovarian germ-cell tumours

(2012) Jeffrey J.H. Low et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

(2012) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

(2012) Peter D Senter et al.   NATURE BIOTECHNOLOGY

Distinct Motifs in the Intracellular Domain of Human CD30 Differentially Activate Canonical and Alternative Transcription Factor NF-κB Signaling

(2012) Sarah L. Buchan et al.   PLoS One

Policies and Reporting Guidelines for Small Biopsy Specimens of Mediastinal Masses

(2011) Alberto Marchevsky et al.   Journal of Thoracic Oncology

Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate

(2010) N. M. Okeley et al.   CLINICAL CANCER RESEARCH

CD30 Expression and Proliferative Fraction in Nontransformed Mycosis Fungoides

(2009) James T. Edinger et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

(2008) S. O. Arulogun et al.   BLOOD

Germ cell tumors of the ovary

(2008) D. Pectasides et al.   CANCER TREATMENT REVIEWS